Reese JS - Search Results

1

Drug selection of mutant methylguanine methyltransferase from different oncoretroviral backbones results in multilineage hematopoietic transgene expression in primary and secondary recipients.

Davis BM, Reese JS, Lingas K, Gerson SL. Davis BM, et al. Among authors: reese js. J Hematother Stem Cell Res. 2003 Aug;12(4):375-87. doi: 10.1089/152581603322286015. J Hematother Stem Cell Res. 2003. PMID: 12965075

2

Transfer of drug resistance genes into hematopoietic progenitors to improve chemotherapy tolerance.

Koç ON, Allay JA, Lee K, Davis BM, Reese JS, Gerson SL. Koç ON, et al. Among authors: reese js. Semin Oncol. 1996 Feb;23(1):46-65. Semin Oncol. 1996. PMID: 8607032 Review.

3

Retroviral transduction of a mutant methylguanine DNA methyltransferase gene into human CD34 cells confers resistance to O6-benzylguanine plus 1,3-bis(2-chloroethyl)-1-nitrosourea.

Reese JS, Koç ON, Lee KM, Liu L, Allay JA, Phillips WP Jr, Gerson SL. Reese JS, et al. Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):14088-93. doi: 10.1073/pnas.93.24.14088. Proc Natl Acad Sci U S A. 1996. PMID: 8943065 Free PMC article.

4

Potentiation of lymphomagenesis by methylnitrosourea in mice transgenic for LMO1 is blocked by O6-alkylguanine DNA-alkyltransferase.

Allay E, Reese JS, McGuire EA, Koç ON, Sedransk N, Gerson SL. Allay E, et al. Among authors: reese js. Oncogene. 1997 Oct 23;15(17):2127-32. doi: 10.1038/sj.onc.1201384. Oncogene. 1997. PMID: 9366529

5

Selection for G156A O6-methylguanine DNA methyltransferase gene-transduced hematopoietic progenitors and protection from lethality in mice treated with O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea.

Davis BM, Reese JS, Koç ON, Lee K, Schupp JE, Gerson SL. Davis BM, et al. Among authors: reese js. Cancer Res. 1997 Nov 15;57(22):5093-9. Cancer Res. 1997. PMID: 9371508

6

Simultaneous protection of G156A methylguanine DNA methyltransferase gene-transduced hematopoietic progenitors and sensitization of tumor cells using O6-benzylguanine and temozolomide.

Reese JS, Davis BM, Liu L, Gerson SL. Reese JS, et al. Clin Cancer Res. 1999 Jan;5(1):163-9. Clin Cancer Res. 1999. PMID: 9918215

7

DeltaMGMT-transduced bone marrow infusion increases tolerance to O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea and allows intensive therapy of 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant human colon cancer xenografts.

Koç ON, Reese JS, Davis BM, Liu L, Majczenko KJ, Gerson SL. Koç ON, et al. Among authors: reese js. Hum Gene Ther. 1999 Apr 10;10(6):1021-30. doi: 10.1089/10430349950018418. Hum Gene Ther. 1999. PMID: 10223735

8

O6-benzylguanine-resistant mutant MGMT genes improve hematopoietic cell tolerance to alkylating agents.

Davis BM, Koç ON, Reese JS, Gerson SL. Davis BM, et al. Among authors: reese js. Prog Exp Tumor Res. 1999;36:65-81. doi: 10.1159/000061986. Prog Exp Tumor Res. 1999. PMID: 10386065 Review. No abstract available.

9

Human long-term culture initiating cells are sensitive to benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea and protected after mutant (G156A) methylguanine methyltransferase gene transfer.

Koç ON, Reese JS, Szekely EM, Gerson SL. Koç ON, et al. Among authors: reese js. Cancer Gene Ther. 1999 Jul-Aug;6(4):340-8. doi: 10.1038/sj.cgt.7700067. Cancer Gene Ther. 1999. PMID: 10419052

10

Human mesenchymal stem cells provide stromal support for efficient CD34+ transduction.

Reese JS, Koç ON, Gerson SL. Reese JS, et al. J Hematother Stem Cell Res. 1999 Oct;8(5):515-23. doi: 10.1089/152581699319966. J Hematother Stem Cell Res. 1999. PMID: 10791902

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters